Chordia Therapeutics, Inc.
1 clinical trials · Sponsor
◉ Watch Chordia Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes (NCT05732103) | Chordia Therapeutics, Inc. | 2023-04-25 |
Track Chordia Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.